🔗 Permalink

Inventor profile of:

Olaf Panknin

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2025-04-10

Top Assignees for applications by Olaf Panknin

The entities that hold a legal rights for patent applications filed by inventor Panknin Olaf:

Bayer Pharma Aktiengesellschaft 17 Berlin, Germany
Bayer Aktiengesellschaft 3 Leverkusen, Germany

Recent patent applications by Panknin Olaf

Olaf Panknin from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-10

US20250114485A1

Human necessities

GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

#2 | 2023-04-13

US20230113481A1

Human necessities

NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

#3 | 2023-04-13

US20230112499A1

Chemistry; metallurgy

FUROINDAZOLE DERIVATIVES

#4 | 2021-07-22

US20210221798A1

Chemistry; metallurgy

HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

#5 | 2021-03-25

US20210085656A1

Human necessities

Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors

#6 | 2020-11-12

US20200353104A1

Human necessities

Gadolinium chelate compounds for use in magnetic resonance imaging

#7 | 2020-09-10

US20200283420A1

Chemistry; metallurgy

High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging

#8 | 2019-11-21

US20190350910A1

Human necessities

SUBSTITUTED DIHYDROIMIDAZOPYRIDINEDIONES AS MKNK1 AND MKNK2 INHIBITORS

#9 | 2019-03-21

US20190083659A1

Human necessities

Gadolinium chelate compounds for use in magnetic resonance imaging

#10 | 2019-02-28

US20190062285A1

Chemistry; metallurgy

Benzimidazol-2-amines as mIDH1 inhibitors

#11 | 2018-08-02

US20180215717A1

Chemistry; metallurgy

Fused imidazoles as mIDH1 inhibitors

#12 | 2018-07-26

US20180207137A1

Human necessities

2-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitors

#13 | 2018-07-19

US20180201585A1

Chemistry; metallurgy

5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors

#14 | 2018-06-21

US20180170882A1

Chemistry; metallurgy

N-Methylbenzimidazoles as mIDH1 inhibitors

#15 | 2018-06-21

US20180169274A1

Human necessities

Gadolinium chelate compounds for use in magnetic resonance imaging

#16 | 2017-11-09

US20170319549A1

Human necessities

1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors

#17 | 2017-07-13

US20170197922A1

Chemistry; metallurgy

Benzimidazol-2-amines as MIDH1 inhibitors

#18 | 2017-07-13

US20170197921A1

Chemistry; metallurgy

Benzimidazol-2-amines as mIDH1 inhibitors

#19 | 2016-02-25

US20160052936A1

Chemistry; metallurgy

SPIROINDOLINE DERIVATIVES FOR USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS

#20 | 2014-12-04

US20140357655A1

Chemistry; metallurgy

SPIROINDOLINE DERIVATIVES AS GONADOTROPIN- RELEASING HORMONE RECEPTOR ANTAGONISTS

InventorID:

992491 ⎘